Zinnia Li

Zinnia Li has over 10 years of experience in the pharmaceutical industry, with a focus on analytical development and quality control. Zinnia has held various leadership roles in companies such as REVOLUTION Medicines, Corcept Therapeutics, Gilead Sciences, ArQule, Sunovion Pharmaceuticals, Armstrong Pharmaceuticals Inc, and Aerodyne Research. Throughout their career, Zinnia has managed teams and collaborated with cross-functional teams to support projects from early-stage development to NDA submission. Zinnia has expertise in method development, validation, and transfer, as well as GMP release and stability testing. Zinnia has also provided analytical support for formulation development, toxicity studies, and process optimization. Zinnia has a strong foundation in HPLC/UPLC, GC/MS, and LC/MS/MS techniques. Zinnia is highly experienced in working with CROs and has a track record of successfully completing analytical method transfers and validations. Zinnia is skilled in troubleshooting and has the ability to improve methods to enhance efficiency. Zinnia has contributed to FDA responses and been involved in ANDA filings.

Zinnia Li's education history begins with their pursuit of a Ph.D. in Physical/Analytical Chemistry at Boston University, from 1999 to 2005. Following this, they took on a Postdoctoral Scientist role at the University of Maryland, specializing in Physical/Analytical Chemistry from 2005 to 2006.

In 2019, Zinnia Li obtained a certificate in Regulatory Affairs from UC Berkeley Extension, where they studied for a year until 2020. Additionally, they hold a Bachelor's and Master's degree from Nanjing University, although the specific field of study for these degrees is not provided.

Aside from their formal education, Zinnia Li has obtained several certifications. In 2019, they completed the Creativity Bootcamp offered by LinkedIn. Zinnia also acquired a Certificate in Regulatory Affairs from UC Berkeley Extension, though the exact month of obtaining this certification is not specified. More recently, in 2022 and 2023, they completed the leadership development programs "From the Laboratory to Leadership" and "Leadership EDGE for Women," respectively, both offered by The Leadership Edge.